Table 2.
6 Months |
12 Months |
6 Months |
12 Months |
|||||
---|---|---|---|---|---|---|---|---|
WT | 5αR1−/− | WT | 5αR1−/− | WT | 5αR2−/− | WT | 5αR2−/− | |
Body weight, g | 38.5 ± 3.6 | 42.6 ± 1.4 | 46.2 ± 3.9 | 43.7 ± 1.6 | 37.0 ± 2.4 | 43.5 ± 1.0b | 42.5 ± 5.7 | 40.6 ± 2.8 |
LBWR | 0.05 ± 0.01 | 0.09 ± 0.01b | 0.10 ± 0.01 | 0.10 ± 0.01 | 0.05 ± 0.00 | 0.05 ± 0.00 | 0.12 ± 0.01 | 0.09 ± 0.01 |
Fasting glucose, mmol/L | 9.6 ± 1.2 | 9.3 ± 0.8 | 8.4 ± 0.3 | 8.3 ± 0.4 | 9.1 ± 0.4 | 9.7 ± 0.8 | 8.8 ± 1.2 | 9.1 ± 0.9 |
2 h glucose, mmol/L | 21.9 ± 4.9 | 20.3 ± 3.6 | 23.5 ± 3.2 | 19.3 ± 1.8 | 15.3 ± 1.1 | 20.2 ± 3.5 | 15.1 ± 2.9 | 17.7 ± 5.2 |
GTT AUC, mmol/L·h | 1604 ± 181 | 1047 ± 211 | 2519 ± 254 | 2164 ± 171 | 1349 ± 95 | 1700 ± 294 | 1709 ± 190 | 2248 ± 460 |
AST, IU/L | 171 ± 71 | 482 ± 158 | 427 ± 73 | 359 ± 91 | 151 ± 23 | 125 ± 25 | 231 ± 44 | 265 ± 46 |
ALT, IU/L | 140 ± 88 | 352 ± 116 | 303 ± 38 | 336 ± 37 | 86 ± 21 | 60 ± 13 | 202 ± 62 | 156 ± 41 |
AST/ALT ratio | 1.97 ± 0.4 | 1.45 ± 0.1 | 1.39 ± 0.2 | 0.72 ± 0.2b | 2.73 ± 0.3 | 2.33 ± 0.5 | 1.75 ± 0.8 | 2.6 ± 0.8 |
Circulating FFA, nmol/μl | 0.46 ± 0.07 | 0.55 ± 0.06 | 0.57 ± 0.06 | 0.46 ± 0.04 | 0.50 ± 0.03 | 0.44 ± 0.06 | 0.48 ± 0.09 | 0.30 ± 0.07 |
Hepatic FFA, nmol/mg | 1.90 ± 0.15 | 1.66 ± 0.07 | 1.81 ± 0.14 | 1.97 ± 0.14 | ||||
α-SMA, % positive area | 2.26 ± 0.4 | 2.29 ± 0.1 | 1.64 ± 0.4 | 1.28 ± 0.14 |
Abbreviation: AUC, area under the curve.
All data are expressed as mean ± SEM.
P < .05 vs WT.